Therapy Areas: Devices
ProBio and Kun Tuo collaborate to deliver integrated CDMO-CRO solutions for advanced therapies
17 September 2026 - ProBio Inc, a global contract development and manufacturing organisation (CDMO) involved in biologics and cell and gene therapies (CGT), announced on Wednesday a strategic collabor...
Myosin Therapeutics chosen for 2026-2027 NCI Investor Initiatives Showcase
17 September 2026 - Myosin Therapeutics Inc, a clinical-stage biotechnology company developing a new class of therapies targeting cancer cell mechanics, announced on Thursday its selection as a 2026&n...
Medtronic receives FDA clearance for LigaSure RAS Maryland instrument on Hugo system
16 September 2026 - Healthcare technology company Medtronic (NYSE: MDT) announced on Wednesday that it has received US Food and Drug Administration clearance for its LigaSure RAS Maryland jaw device f...
Aptar and Aceso Therapeutics partner to advance inhaled cystic fibrosis therapy
7 September 2026 - Aptar Pharma, a provider of drug delivery, dosing, protection technologies and services and part of AptarGroup Inc (NYSE:ATR), announced on Monday that it has partnered with Aceso T...
Immuron signs US distribution deal for PROIBS
4 September 2026 - Australian biopharmaceutical company Immuron Limited (ASX: IMC; NASDAQ: IMRN), which develops and commercialises targeted polyclonal antibodies for infectious diseases, announced on...
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
24 August 2026 - Medical technology company Tempus AI Inc (NASDAQ: TEM) reported on Monday that it has received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, an AI-ena...